| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.0M | +29.8% |
| Cost of Revenue | $13.3M | +21.6% |
| Gross Profit | $10.7M | +41.6% |
| R&D Expense | $1.6M | +23.1% |
| SG&A Expense | $11.9M | +1.1% |
| Operating Income | -$1.2M | +71.5% |
| Pre-tax Income | -$363K | +91.5% |
| Income Tax | $0 | — |
| Net Income | -$363K | +91.5% |
| EPS (Basic) | -$0.23 | +92.2% |
| EPS (Diluted) | -$0.23 | +92.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.7M | +90.9% |
| Accounts Receivable | $2.0M | +148.3% |
| Inventory | $935K | +29.1% |
| Current Assets | $6.0M | +75.0% |
| Total Assets | $21.3M | +25.4% |
| Current Liabilities | $3.8M | -12.2% |
| Long-term Debt | $83K | -78.3% |
| Total Liabilities |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $685K | +56.0% |
| Capital Expenditures | $326K | +46.2% |
| Investing Cash Flow | -$326K | -46.2% |
| Financing Cash Flow | $903K | +374.5% |
| Free Cash Flow | $359K | +66.2% |
| $6.8M |
| +37.8% |
| Stockholders' Equity | $14.6M | +20.4% |